Sleep.ai’s $5.5 million in funding was led by Treasure Coast Ventures and included participation from Nurture Ventures, the Harvard Business School Alumni Angels of Greater New York and Supermoon Capital.
The post Sleep.ai Secures $5.5M to Scale Sleep Intelligence Platform appeared first on MedCity News.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
